Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis
- PMID: 21641104
- DOI: 10.1016/j.ejogrb.2011.04.010
Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis
Abstract
The aim of this study is to review literature about the efficacy of low dose aspirin (LDA) and vitamins C/E (VCE) to prevent pre-eclampsia in women at high and low risk. Randomized clinical trials were included and stratified for high and low risk women. Inclusion criteria were: assignment of patients in treated or placebo groups, definition of pre-eclampsia according to the guidelines of the International Society for the Study of Hypertension in Pregnancy. Exclusion criteria were: omitting at least one of the inclusion criteria, trials involving women with pre-eclampsia at trial entry, studies investigating hypertensive disorders other than pre-eclampsia, prophylaxis of intrauterine growth restriction with low-dose aspirin or vitamins C/E, non-randomized studies and data reported in graphs or percentages. The incidence of pre-eclampsia, perinatal outcomes and adverse effects attributable to LDA and VCE were compared between treated women and placebo. Inter-studies heterogeneity was tested. P<0.05 was considered significant. pooled odds ratios (OR) with 95% confidence intervals (95% CI) were calculated. PRISMA guidelines were followed. Fifteen studies were pooled. LDA did not decrease the incidence of pre-eclampsia in high-risk (396/5025 - 8% vs placebo: 464/5027 - 9%; P=0.05; OR: 0.72; 95% CI: 0.51-1.00) and low-risk (137/4939 - 3% vs placebo: 166/4962 - 3%; P=0.10; OR: 0.82; 95% CI: 0.65-1.04) women. Similarly, VCE did not reduce the incidence of pre-eclampsia in high-risk (VCE: 250/1744 - 14% vs placebo: 275/1741 - 16%; P=0.24; OR: 0.84; 95% CI: 0.63-1.12) and low-risk (VCE: 56/935 - 6% vs placebo 47/942 - 5%; P=0.57; OR: 1.20; 95% CI: 0.82-1.75) women. In high-risk women, other hypertensive disorders were more frequent in VCE (121/1692 - 7%) than placebo (79/1693 - 5%; P=0.002). Perinatal outcomes were not improved by LDA or VCE.
Conclusion: there is no evidence to support the administration of LDA or VCE to prevent pre-eclampsia.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.Ultrasound Obstet Gynecol. 2003 Sep;22(3):233-9. doi: 10.1002/uog.218. Ultrasound Obstet Gynecol. 2003. PMID: 12942493 Clinical Trial.
-
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.Ultrasound Obstet Gynecol. 2013 May;41(5):491-9. doi: 10.1002/uog.12421. Ultrasound Obstet Gynecol. 2013. PMID: 23362106
-
An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol.Contemp Clin Trials. 2016 Jul;49:143-8. doi: 10.1016/j.cct.2016.07.003. Epub 2016 Jul 6. Contemp Clin Trials. 2016. PMID: 27394381 Clinical Trial.
-
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.Am J Obstet Gynecol. 2017 Feb;216(2):110-120.e6. doi: 10.1016/j.ajog.2016.09.076. Epub 2016 Sep 15. Am J Obstet Gynecol. 2017. PMID: 27640943 Review.
-
Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials.BJOG. 2013 Jan;120(1):64-74. doi: 10.1111/j.1471-0528.2012.03493.x. Epub 2012 Nov 6. BJOG. 2013. PMID: 23126307 Review.
Cited by
-
Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview.High Blood Press Cardiovasc Prev. 2023 Jul;30(4):289-303. doi: 10.1007/s40292-023-00582-5. Epub 2023 Jun 13. High Blood Press Cardiovasc Prev. 2023. PMID: 37308715 Free PMC article. Review.
-
Placenta in the Critically Ill Mother.Indian J Crit Care Med. 2021 Dec;25(Suppl 3):S200-S205. doi: 10.5005/jp-journals-10071-24024. Indian J Crit Care Med. 2021. PMID: 35615604 Free PMC article.
-
Effects of prenatal micronutrients supplementation timing on pregnancy-induced hypertension: Secondary analysis of a double-blind randomized controlled trial.Matern Child Nutr. 2021 Jul;17(3):e13157. doi: 10.1111/mcn.13157. Epub 2021 Feb 16. Matern Child Nutr. 2021. PMID: 33594802 Free PMC article. Clinical Trial.
-
Effects of Maternal Nutritional Supplements and Dietary Interventions on Placental Complications: An Umbrella Review, Meta-Analysis and Evidence Map.Nutrients. 2021 Jan 30;13(2):472. doi: 10.3390/nu13020472. Nutrients. 2021. PMID: 33573262 Free PMC article. Review.
-
Role of Palm Oil Vitamin E in Preventing Pre-eclampsia: A Secondary Analysis of a Randomized Clinical Trial Following ISSHP Reclassification.Front Med (Lausanne). 2021 Jan 21;7:596405. doi: 10.3389/fmed.2020.596405. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33553199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical